Loading...
111, Inc.
YI•NASDAQ
HealthcareMedical - Pharmaceuticals
$8.14
$-0.21(-2.57%)
111, Inc. (YI) Financial Performance & Statements
Review 111, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-3.66%
↓ 3.66%
Operating Income Growth
100.60%
↑ 100.60%
Net Income Growth
83.51%
↑ 83.51%
Operating Cash Flow Growth
158.81%
↑ 158.81%
Operating Margin
0.01%
↑ 0.01%
Gross Margin
5.15%
↑ 5.15%
Net Profit Margin
-0.45%
↓ 0.45%
ROE
10.44%
↑ 10.44%
ROIC
0.47%
↑ 0.47%
111, Inc. (YI) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for 111, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.85B | $3.60B | $3.42B | $3.53B |
| Cost of Revenue | $3.65B | $3.39B | $3.30B | $3.32B |
| Gross Profit | $202.48M | $210.62M | $119.54M | $208.53M |
| Gross Profit Ratio | $0.05 | $0.06 | $0.03 | $0.06 |
| R&D Expenses | $0.00 | $0.00 | $18.37M | $18.31M |
| SG&A Expenses | $96.33M | $91.32M | $97.72M | $99.43M |
| Operating Expenses | $209.80M | $208.25M | $116.20M | $204.81M |
| Total Costs & Expenses | $3.86B | $3.60B | $3.42B | $3.52B |
| Interest Income | $1.47M | $1.53M | $2.08M | $1.97M |
| Interest Expense | $5.26M | $7.81M | $7.28M | $7.98M |
| Depreciation & Amortization | $0.00 | $1.98M | $1.89M | -$3.72M |
| EBITDA | -$7.28M | $4.35M | $5.23M | $5.35M |
| EBITDA Ratio | -$0.002 | $0.001 | $0.002 | $0.002 |
| Operating Income | -$7.32M | $2.37M | $3.34M | $3.72M |
| Operating Income Ratio | -$0.002 | $0.001 | $0.001 | $0.001 |
| Other Income/Expenses (Net) | -$5.22M | -$5.83M | -$5.38M | -$6.36M |
| Income Before Tax | -$12.54M | -$3.46M | -$2.04M | -$2.63M |
| Income Before Tax Ratio | -$0.003 | -$0.001 | -$0.001 | -$0.001 |
| Income Tax Expense | $3000.00 | $5000.00 | $37000.00 | $51000.00 |
| Net Income | -$19.84M | -$17.11M | -$14.02M | -$13.78M |
| Net Income Ratio | -$0.005 | -$0.005 | -$0.004 | -$0.004 |
| EPS | -$2.30 | -$1.98 | -$1.64 | -$1.60 |
| Diluted EPS | -$2.30 | -$1.98 | -$1.64 | -$1.60 |
| Weighted Avg Shares Outstanding | $8.64M | $8.60M | $8.57M | $8.56M |
| Weighted Avg Shares Outstanding (Diluted) | $8.64M | $8.60M | $8.57M | $8.56M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan